Study Summary
This phase 1 / 2 study will evaluate the response of B-cell malignancies expressing CD19 to autologous T cells transduced with a second generation anti-CD19 chimeric antigen receptor in children and young adults.
Want to learn more about this trial?
Request More InfoInterventions
CD19 CAR T cellsBIOLOGICAL
Autologous T cells activated and transduced with a chimeric antigen receptor targeting CD19
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| Chaim Sheba Medical Center | Ramat Gan | Israel |